Common Contracts
2 similar Trial Agreement contracts
CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDII for Protocol ACE-536-MDS-002 pro Protokol ACE-536-MDS-002 This clinical trial agreement (hereinafter, the “Agreement”) is by and between: Tato Smlouva o klinické studii (dále „Smlouva”), byla uzavřena...Trial Agreement • March 14th, 2022
MUDr. Olga Černá, with DOB XXX, residing at XXX (hereinafter the “Investigator”); MUDr. Olgou Černou, s datem narození XXX, bytem na adrese XXX (dále „Zkoušející”); individually or collectively, as the case may be, referred hereto as the “Party” or “Parties”. jednotlivě nebo případně společně dále „Strana” nebo„Strany”. The Institution and the Investigator are hereinafter called “Institution/Investigator” when it is intended that they be referred to jointly. Zdravotnické zařízení a Zkoušející jsou dále společně označováni jako „Zdravotnické zařízení/Zkoušející”, pokud z kontextu vyplývá, že se odkazuje na oba společně. This Agreement is valid as of the last date of signature below and effective as of the date when it is published in Contracts Register (the “Effective Date”). Tato Smlouva nabývá platnosti ke dni posledního podpisu níže a účinnosti dnem zveřejnění v registru smluv (dále „Datum účinnosti“). WHEREAS VZHLEDEM K TOMU, ŽE (a) The Sponsor conducts business in the development o
ContractTrial Agreement • February 9th, 2022
CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDII for Protocol ACE-536-MDS-002 pro Protokol ACE-536-MDS-002 This clinical trial agreement (hereinafter, the “Agreement”) is by and between: Tato Smlouva o klinické studii (dále „Smlouva”),byla uzavřena mezi těmito stranami: Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA represented for the purposes of this Agreement by Celgene International II Sàrl, a limited liability company organized under the laws of Switzerland having its principal office at Route de Perreux 1, 2017 Boudry, Switzerland (hereinafter the “Sponsor”)For the only purposes of signing this Agreement Sponsor is represented by PPD Investigator Services LLC, a company organized under the laws of the State of Delaware having its principal office at 929 North Front Street, Wilmington NC 28401, USA, company ID no.: 46-2919241. Celgene Corporation s hlavním sídlem v 86 Morris Avenue, Summit, NJ 07901, USA, zastupovaná pro účely této Sm
